Analystreport

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) was given a new $11.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com